Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? (Q42046045)

15 October 2017

Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? (English)

1 reference

15 October 2017

0 references

Dirk J van Veldhuisen

series ordinal

3

object named as

Dirk J van Veldhuisen

1 reference

15 October 2017

2

Adriaan A Voors

1 reference

15 October 2017

Iwan C C van der Horst

series ordinal

1

1 reference

15 October 2017

15 February 2007

1 reference

Clinical Research in Cardiology

15 October 2017

1 reference

15 October 2017

96

1 reference

15 October 2017

4

1 reference

15 October 2017

193-195

1 reference

The new biology of aldosterone

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

The nongenomic actions of aldosterone

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Aldosterone, ion channels, and sudden death: another piece of the circle?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779440

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17294352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17294352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chronic beta-blocker treatment in patients with advanced heart failure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17294352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00392-007-0487-Y

1 reference

15 October 2017

1 reference

PMC publication ID

2779440

15 October 2017

PubMed publication ID

17294352

1 reference

PMC publication ID

2779440